Page 21 - Read Online

Peng et al. Microbiome Res Rep 2024;3:5 https://dx.doi.org/10.20517/mrr.2023.47 Page 15 of 17

38. He H, Yi L, Zhang B, et al. USP24-GSDMB complex promotes bladder cancer proliferation via activation of the STAT3 pathway. Int
J Biol Sci 2021;17:2417-29. DOI PubMed PMC
39. Jiang N, Liao Y, Wang M, et al. BUB1 drives the occurrence and development of bladder cancer by mediating the STAT3 signaling
pathway. J Exp Clin Cancer Res 2021;40:378. DOI PubMed PMC
40. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and
treatment options. Nat Rev Microbiol 2015;13:269-84. DOI PubMed PMC
41. McLellan LK, Hunstad DA. Urinary Tract Infection: Pathogenesis and outlook. Trends Mol Med 2016;22:946-57. DOI PubMed
PMC
42. Santos LL, Santos J, Gouveia MJ, et al. Urogenital schistosomiasis-history, pathogenesis, and bladder cancer. J Clin Med
2021;10:205. DOI PubMed PMC
43. Wu S, Rhee KJ, Zhang M, Franco A, Sears CL. Bacteroides fragilis toxin stimulates intestinal epithelial cell shedding and gamma-
secretase-dependent E-cadherin cleavage. J Cell Sci 2007;120:1944-52. DOI PubMed PMC
44. Chung L, Thiele Orberg E, Geis AL, et al. Bacteroides fragilis toxin coordinates a pro-carcinogenic inflammatory cascade via
targeting of colonic epithelial cells. Cell Host Microbe 2018;23:203-14.e5. DOI PubMed PMC
45. Wang X, Yang Y, Huycke MM. Commensal-infected macrophages induce dedifferentiation and reprogramming of epithelial cells
during colorectal carcinogenesis. Oncotarget 2017;8:102176-90. DOI PubMed PMC
46. Huang H, Fan X, Zhang X, Xie Y, Ji Z. LncRNA CARLo-7 facilitates proliferation, migration, invasion, and EMT of bladder cancer
cells by regulating Wnt/β-catenin and JAK2/STAT3 signaling pathways. Transl Androl Urol 2020;9:2251-61. DOI PubMed PMC
47. Jiang LJ, Guo SB, Huang ZY, et al. PHB promotes bladder cancer cell epithelial-mesenchymal transition via the Wnt/β-catenin
signaling pathway. Pathol Res Pract 2023;247:154536. DOI
48. Kotolloshi R, Gajda M, Grimm MO, Steinbach D. Wnt/β-catenin signalling and its cofactor BCL9L have an oncogenic effect in
bladder cancer cells. Int J Mol Sci 2022;23:5319. DOI PubMed PMC
49. Korac-Prlic J, Degoricija M, Vilović K, et al. Targeting Stat3 signaling impairs the progression of bladder cancer in a mouse model.
Cancer Lett 2020;490:89-99. DOI
50. Oresta B, Braga D, Lazzeri M, et al. The microbiome of catheter collected urine in males with bladder cancer according to disease
stage. J Urol 2021;205:86-93. DOI
51. Nejman D, Livyatan I, Fuks G, et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science
2020;368:973-80. DOI PubMed PMC
52. Galeano Niño JL, Wu H, LaCourse KD, et al. Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer.
Nature 2022;611:810-7. DOI PubMed PMC
53. Li Q, Chan H, Liu WX, et al. Carnobacterium maltaromaticum boosts intestinal vitamin D production to suppress colorectal cancer in
female mice. Cancer Cell 2023;41:1450-65.e8. DOI
54. Zhang Y, Wang W, Zhou H, Cui Y. Urinary Eubacterium sp. CAG:581 promotes non-muscle invasive bladder cancer (NMIBC)
development through the ECM1/MMP9 pathway. Cancers 2023;15:809. DOI PubMed PMC
55. Hezaveh K, Shinde RS, Klötgen A, et al. Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-
associated macrophages to suppress anti-tumor immunity. Immunity 2022;55:324-40.e8. DOI PubMed PMC
56. Bender MJ, McPherson AC, Phelps CM, et al. Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates
immune checkpoint inhibitor treatment. Cell 2023;186:1846-62.e26. DOI PubMed PMC
57. Jia W, Xie G, Jia W. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat Rev Gastroenterol
Hepatol 2018;15:111-28. DOI PubMed PMC
58. Collins SL, Stine JG, Bisanz JE, Okafor CD, Patterson AD. Bile acids and the gut microbiota: metabolic interactions and impacts on
disease. Nat Rev Microbiol 2023;21:236-47. DOI PubMed
59. Kalaora S, Nagler A, Nejman D, et al. Identification of bacteria-derived HLA-bound peptides in melanoma. Nature 2021;592:138-43.
DOI PubMed PMC
60. Samuelsson P, Hang L, Wullt B, Irjala H, Svanborg C. Toll-like receptor 4 expression and cytokine responses in the human urinary
tract mucosa. Infect Immun 2004;72:3179-86. DOI PubMed PMC
61. Ching C, Schwartz L, Spencer JD, Becknell B. Innate immunity and urinary tract infection. Pediatr Nephrol 2020;35:1183-92. DOI
PubMed PMC
62. Johnson DE, O'Keefe RA, Grandis JR. Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat Rev Clin Oncol 2018;15:234-
48. DOI PubMed PMC
63. Gatta LB, Melocchi L, Bugatti M, et al. Hyper-activation of STAT3 sustains progression of non-papillary basal-type bladder cancer
via FOSL1 regulome. Cancers 2019;11:1219. DOI PubMed PMC
64. Alfaro C, Sanmamed MF, Rodríguez-Ruiz ME, et al. Interleukin-8 in cancer pathogenesis, treatment and follow-up. Cancer Treat
Rev 2017;60:24-31. DOI
65. Fluckiger A, Daillère R, Sassi M, et al. Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal
bacteriophage. Science 2020;369:936-42. DOI PubMed
66. Jin C, Lagoudas GK, Zhao C, et al. Commensal microbiota promote lung cancer development via γδ T cells. Cell 2019;176:998-1013.
e16. DOI PubMed PMC
67. Xue C, Li G, Zheng Q, et al. Tryptophan metabolism in health and disease. Cell Metab 2023;35:1304-26. DOI